Latest news
IBRX Stokes Retail Chatter — Investors See Anktiva Beat Merck’s Keytruda With Approval In EU - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 11:34:22 GMTMerck Splits Oncology, Specialty Operations To Brace For Keytruda Patent Loss – Overhauls Leadership To Drive Growth - stocktwits.comstocktwits.com · Fri, 07 Aug 2026 04:30:58 GMT